Visar inlägg med etikett India. Visa alla inlägg
Visar inlägg med etikett India. Visa alla inlägg

fredag 28 februari 2020

A week of high- level visits

Sweden was host for the third Global Ministerial Road Safety Conference last week that gathered a lot of interesting high-level officials from all over the world. Swecare got the opportunity to meet and arrange meetings with visitors from Nigeria, Qatar, India and Kazakhstan aside from the conference.



We hosted a meeting with Sheikh Dr. Mohammed Bin Hamad Bin J. Al-Thani who has been the Director of Public Health at the Supreme Council of Health in Qatar since 2008. He presented their National Health Strategy 2018-2022 and more in depth the Public Health Strategy 2017- 2022It was a popular event and all seats were taken. We managed to make sure the participants got a one-to-one conversation with him about each specific area of interest from; Mentice, Karolinska Institute, Elekta, Bactiguard, Global Pharma Consulting, Xinix, Stockholm Care and Calmark.



On Thursday we had a round table meeting hosted by state secretary Maja Fjaestad that welcomed a Nigerian delegation headed by Mr. B Mustapha, Secretary to the Government, and included Dr. E Osagie Ehanire, Minister for Health and Rt. Hon. Rotimi Amaechi, Minister for Transportation. Even though our countries in size and population are very different we still have common challenges such as access to health care in rural areas. With us on the Swedish side we had; Byon8, Hack for Sweden, Bactiguard, Grace Health, Elekta, Sweco and Pansanté.




Finally, with quite short notice, state secretary Maja Fjaestad received the vice minister for Health from Kazakhstan, Mr. Kamalzhan Nadyrov. Swecare participated in the meeting to represent the Swedish companies. Mr. Nadyrov expressed great interest in Swedish Healthcare and Swedish solutions. Kazakhstan is planning substantial reforms of the Healthcare system. Many existing hospitals and medical facilities are being upgraded and 23 new multifunctional hospitals are to be built by 2025. Areas of special interest that were mentioned were development of primary care, prevention, digitalization, medical records, cancer managementand infection prevention and antibiotic resistance.

onsdag 26 februari 2020

Join the initiative Vision Zero for Healthcare-Associated Infections in India!


Actors from academia and the public and private sectors met in Stockholm on a sunny afternoon last week to talk about healthcare-associated infections in India and how to combat them. The background is an initiative taken by Swedish companies Essity, EMPE Diagnostics and Bactiguard, to take a lead position towards combatting healthcare-associated infections in India. The first steps to "Vision Zero on Healthcare-Associated Infections" were taken during the delegation trip to India in February 2019, headed by Minister for Health Lena Hallengren.

Healthcare-Associated Infections (HAIs) are an important public health problem globally. HAIs occur worldwide and affect all countries, irrespective of their degree of development. +50% of all HAI are caused by bacterial growth on medical devices, such as catheters. They represent a significant burden among patients, health-care workers and health systems - but are in many cases preventable. In India, it is estimated that more than 2 million people are affected each year.



Cecilia Edström, recently appointed CEO of Bactiguard, introduced the seminar by saying that she is a a strong believer in the triple helix approach, where academia and public and private sectors can work towards the same goal. This initiative is an attempt to build collaborative ecosystems in healthcare across India, to capture the learning’s of Sweden and contribute towards leading the path of substantially reduced HAI in India -  to reduce infections, reduce complications for patients, free up bed capacity and lower the cost of treatment.


The pre-study that has been done was presented by Aticka Chona, consultant at Green Karmas. The study’s purpose was to clearly understand the expectations of the Indian authorities and healthcare industry, and to develop a structure and engagement plan to take forward the co-operation. The pre-study has also raised awareness and interest among various public and private care providers, such as AIIMS, Max, Medanta, Apollo and the Healthcare Sector Skills Council. The interest from the Indian side in the vision has been keen interest, which has been beneficial for the founding companies.
All of the actors said that they know which their challenges are, and what can be done – but they need to learn HOW to do that and how others have done it. The answer lies in Education, education, education. Swedish healthcare is well-known and our work on infection control can be a role model. They know learn more about pre-diagnosis, to build a digital solution based on what has been done in Sweden but then adapted to Indian conditions and they would like continuous contact – handholding – on how to address infections in the hospitals.

The continuation of the project is planned in two phases. The first one will focus on ICU challenges, and the second will be focused on general hospitals challenges. The work will be done through a series of joint working groups between Swedish companies, Indian hospitals and healthcare organizations on the topic of HAI.



The present group of Swedish companies and the Indian hospitals are now ready to take the next step, to bring global best practices, data and knowledge from Sweden to Indian healthcare actors. By joining the Vision Zero for HAI in India, partners can work towards the same goal and actually make a difference. This can then serve as a basis for business opportunities for the Swedish companies – getting access to a chain of hospital through only one entry point is a great advantage!

The initiative is now looking for more Swedish stakeholders that want to share their expertise and solutions, and to capitalize on the work already done for Vision Zero for HAI in India. For more information, please contact aticka.chona[@[greenkarmas.com or anna.riby[a]Swecare.se.



tisdag 10 december 2019

What's next in India

While we celebrate the conclusion of the Sweden-India Year of Health, we have already initiated the next stage of our close collaboration. The new decade will bring increased activity within both midwifery and elderly care, covering both ends of the spectrum where Swedish solutions are particularly sought after.



The importance of digital health will only increase, especially with regards to the management of chronic conditions, but here we hope to develop applications and medtech products with Indian innovators which can be applied in both markets in order to ease the enormous health care burden we face. The combination of longitudinal data from Sweden with volumes available in India could lead to significantly more efficient solutions. New agreements can also be expected within infectious diseases, in particular with regards to Anti-Microbial Resistance.


All this and much more was discussed during the State Visit to India last week. Swecare organised the Elderly Care tract with special focus on dementia, ripples of our dialogue with key opinion leaders can already be felt in the Indian health care community. Minister Harsh Vardhan and State Secretary Maja Fjaestad reasserted their commitment to the MoU which exists between our two countries. The Minister has already expressed his interest in visiting Sweden early next year.

MAMTA Founder and long-time Swecare partner Dr Mehra receiving the Royal Order of Seraphim & the Royal Order of Polar Star




fredag 31 maj 2019

Converting Agreements into Action: Sweden-India Year of Health







Swecare had the privilege of welcoming a delegation from India organised by our longtime partner InnovatioCuris.
Region Uppsala


Highlights included a highly engaging round table discussion with key Swedish innovators at the incomparable H2 Health Hub in Stockholm and a seminar at Vitalis in Gothenburg.

Aula Medica - KI
The delegation visited Karolinska Institute and Hospital in Solna, Uppsala Region and University, Surgical Science, Sahlgrenska, AstraZeneca's BioVentureHub, and GoCo Health Innovation City during their 4-day trip.

The focus of the delegation was to explore concrete collaboration opportunities between innovators in our two countries - taking the Innovation Partnership signed by Modi and Löfven last year to the next level.











Delegates

VR at Surgical Science
  • Dr Sandeep Bhalla, Director of Training, Public Health Foundation of India (PHFI): leading the capacity building initiatives for Primary care physicians in chronic disease management and injuries .
  • Deepali Jetley, Qwazent: Managing Partner from an all-female executive search firm with health care focus.
  • Kingshuk Poddar, AIC-AMTZ Medivalley Incubation Council: a comprehensive entrepreneur incubation hub catering to convergence technologies in the field of Medtech, Nutratech and Biotech.
  • Rohini Pimple, Research and Innovation Circle of Hyderabad (RICH): an initiative conceived to unlock the national treasure created by the top scientific research institutions in Telangana State, and to actively facilitate the process of taking their research to market.
  • Rajesh R. Singh, Wadhwani Initiative for Sustainable Healthcare (WISH) Foundation: improving the quality of and access to primary healthcare for under-served communities in India by appropriately introducing promising healthcare innovations in the public health system.
  • Sachin Gaur, InnovatioCuris: expert in cyber security and frugal innovations in health care.
  • Dr VK Singh, InnovatioCuris: veteran doctor with a decades long career in the Indian military and extensive network in India.
If you were unable to join us during last week's activities and are interested in pursuing any of these contacts, please get in touch. Further information: InnoBRIDGE 2019.

Upcoming projects & activities (email Swecare if interested):
Linda Swirtun, Vinnova
  • New Initiative - building a much broader and stronger platform in infection control, where as many Swedish institutions and companies as possible are engaged, establishing a Vision Zero for hospital acquired infections, similar to what has been done for road traffic accidents in Sweden and now exported to India.
  • Strengthening Collaboration - reducing environmental risks from antibiotic production & sustainable solutions through building alliances. On the issue, Stockholm International Water Institute (SIWI) suggests a multi stakeholder call for action.
  • Vinnova Call - company-driven research and innovation projects (Smart Cities & Clean Energy, Digitisation & IoT). Deadline 15 August - more information.
  • Incoming visit - Director of AIIMS Jodhpur 12-14 June.

Seminar at Vitalis 2019

fredag 30 november 2018

2019: Planning for the Year Ahead

Sweden & India - Partners in Health

A commitment has now been made by both the Swedish Socialdepartementet and the Indian Ministry of Health and Family Welfare to make 2019 the Year of Health - #SwedenIndiaHealth2019. As we plan for the year ahead, we welcome your input as your engagement is crucial to this partnership. The focus will be on aligning Swedish Triple Helix life science actors in delivering a structured solution to common challenges in India. Concrete deliverables along the care continuum is the ultimate objective of this collaboration. Once this proof of concept yields results - increased efficiency, decreased costs, healthier community - the Indian government has expressed interest in scaling the concept to other parts of the country. The Indian Ministry suggests Jodhpur, and its new All India Institute of Medical Sciences (AIIMS), as the test bed for this collaboration.

This, of course, does not preclude collaborations in other parts of India and many of our partners and members have ongoing projects throughout the country. We foresee increased activities with AIIMS New Delhi, Apollo Hospitals, Public Health Foundation of India, MaxCure Group, India Institute of Technology in Delhi, Mumbai, Bengaluru, Hyderabad, Kolkata, and Chennai, to name a few. But these will all be conducted with a view to ensure that Swedish stakeholders, despite having distinct objectives, will be moving in the same direction. Partnerships between Swedish actors is encouraged so that the momentum we have generated results in concrete (measurable) outputs.

Proposed timeline for 10-year celebrations in 2019

  • January - pre-feasibility study in Jodhpur to determine scope
  • April/May - heads of Indian hospitals will be invited to Sweden for a study visit and workshop
  • 21-23 May - Vitalis 2019 session to focus on AI & Innovation with an incoming health tech delegation which will visit incubators and hubs in Stockholm and Gothenburg
  • September - agency and private sector workshop in India
  • October/November - Indian Ministerial or Health Secretary visit to Stockholm along with the 11th Joint Working Group meeting

Other dates to keep in mind

  • 5 December - 2nd Private Sector Steering Committee Meeting
  • April/May - Indian elections

Calls out
Focus areas
  • Digital Health - non-communicable diseases, elderly care, AI, Health Tech
  • Anti-Microbial Resistance - infection control, knowledge transfer, nurse training, medtech
May I please request that if you have upcoming activities, you contact us so that we can provide the necessary support both in Sweden and in India? We will be coordinating closely with the Indian Embassy in Stockholm and the Swedish Embassy in New Delhi and one of the proposed ideas is to create a quarterly newsletter highlighting events within the life science sector between our two countries which could also act as a status report so do write to us!


onsdag 19 september 2018

Collaboration across borders to new markets - CBHA Final Seminar

The Central Baltic Health Access program has been part of our work at Swecare for a couple of years now. This interesting collaboration with Swedish Medtech and similar organizations in Finland, Estonia and Latvia to facilitate entry to new markets for our companies, has now come to an end. More information about the program can be found below, or check the label CBHA for all blog entries relating to the program.

The program has involved 65 companies and included home market coaching, target market coaching, tailor-made market information and business missions to all four target markets: India, USA, South Korea, and Uganda. There have even been some sales - not bad considering the long lead times in life science and health care - and several partnership agreements, in addition to the MoUs between the Baltic partners and coaches and organizations in the target markets.


The seminar began with a welcome by Malin Hollmark from Swedish Medtech and Piret Hirv, our program partner from Estonia who was also the moderator of the event. The seminar consisted of presentations from a coach for each market, as well as the sharing of experiences by one or two participating companies per market.

Sachin Gaur from InnovatioCuris, Target Market Coach for India, led the discussions. He presented his recommendations under the title: ´The good, the bad and the ugly´ which was appreciated by the audience. With a population of 1.3 billion and a 90% out-of-pocket expenditure on health care, there is great need for products and services at low prices.

Pavan Asalapuram presented EMPE Diagnostics' story and how their test kits can provide rapid information about drug-susceptibility in TB patients, which simplifies and assists doctors in providing the right treatment. The product has been received with great interest in the market and he will continue to work with Sachin to enter the Indian market. Pavan listed some of the advantages of the program, such as getting exposure and valuable contacts, proper guidance and access to local authorities.

The next market discussed was USA and Nima Jokilaakso, the Swedish local coach from Swecare, presented lessons learned and recommendations for entering the market. Some conclusions were that companies must realize that competition is really fierce in the US market and that in order to succeed you need to do business the "American Way" (don't be shy), to partner with local associations in order to use their network and in-house competence, and make sure you have legal coverage "for when you get sued".


Priit Kruus from the Estonian company Dermtest, that empowers general practitioners in fighting melanoma, expressed his struggle with being a small but growing company and the difficulties in prioritizing. Rasmus Hautala from Finnish Labrotex also shared his experience from the program. Their clearly defined goal of targeting the right key opinion leaders has enabled the company to reach their desired position.

This was followed by an inspirational speech from Birgit Linnamäe, both based on her experience from assisting and preparing companies to enter the South Korean market, as well as her reflections on cultural differences. Interactions between two people can be interpreted in many ways. How people perceive things such as time, space, temperature, family, truth etc are some examples she lifted.

Thomas Lööw from Swedish company Lifeclean presented their CBHA journey which has led to the shipping of one 40 feet container full of Lifeclean disinfectants to South Korea. Thomas mentioned that the program gave Lifeclean the opportunity to be part of a group, and he now realizes how important regular contact and relationships are for the process, both between company and coach, and with partners in the target market. The South Korea part of the seminar was concluded by Julie Yi, target market coach who gave her view of the program.

The last market was Uganda, where Anna Riby from Swecare presented some defining characteristics of the Ugandan market which has a heterogeneous and less regulated structure, with stark differences between city / country, private / public, and high out-of-pocket spending. Important things to consider for market entry are to offer the relevant product for the patient segment and an adapted business model. She also urges companies to use WhatsApp as a means of communication rather than emails and to persevere - it will take time!
Nina Nilsson from Bactiguard began her presentation by discussing September 13 - World Sepsis Day. Every day, every 3rd second someone dies of sepsis. With that said, she gave her input on how Bactiguard is looking at the Ugandan market potential. She described Bactiguard's process for market assessment and distributor selection. They focus on private hospitals since their buying power is much stronger. She confirmed that the process is slow, but they have not given up hope on landing a deal in the future, as demand for high-quality health care is increasing. 
Continuous training for medical staff in infection control and use of the products will be necessary when there is a sale.

The participants were divided into smaller groups for lunch in order to discuss and agree on recommendations for the CBHA team with regards to the program structure, coaching, and common challenges.

After lunch, the group discussions were summarized and the common-thread for all four markets seem to be the advice that a company wanting to access the market has to be willing to spend time onsite – with potential partners – sending occasional emails is not enough. Companies should consider their own resources, collaboration is key, and the local coaches invaluable. Also, it is important to spend time to “teach the coach” – the target market coach needs to understand your needs, your products, and your offer. Plan regular meetings with the both target market coaches and local coaches.


Before bidding farewell, Memoranda of Understanding with partners in the US market were signed by the partners on this side of the Atlantic. The American partners, the Commonwealths of Maryland and Pennsylvania and target market coach Bob Anthony, will sign during a ceremony which is part of the follow-up business mission to the US in a couple of weeks.

The last activity of the program will be a follow-up mission to India, organized by Swecare with the support of InnovatioCuris, after which this segment of the program will be wrapped-up. However, we will continue developing the contacts and networks that the project has resulted in and the Baltic partners have agreed to apply for a second phase, covering new markets, for which the input from the final seminar will be invaluable. So even if this was the Final Seminar, we hope that it will only be one step in the ongoing collaboration with partners in the Baltics and in target markets, so that we can support companies in reaching those distant markets!


CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish organizations to support entrepreneurship in health technologies. The program has facilitated the entry of Estonian, Latvian, Swedish and Finnish health, med and bio- tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provided the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and support in identifying and contacting potential partners. The program has had a strong focus for the companies to achieve sales in the chosen market. The program is financed by the Central Baltic Interreg Program.

fredag 27 april 2018

One crucial factor we often take for granted

In our 40 years, there is one lesson Swecare learned early, and which has been proven time and time again: successfully launching a Swedish healthcare company in a new market requires solid collaboration with a local partner. One with intimate knowledge of the local healthcare systems, long-term relationships with the key players within it, and a determination to do good. As a celebrity recently claimed – healthcare is complicated. Even those working in other industries, including defense, would agree that nowhere does local values, politics, culture, economic means have more impact than in healthcare. Projections of GDP growth, investment figures, risk assessments, population dividend and other macro figures are not enough to determine whether a product or service from within the Swedish healthcare and life science sector will be successful in a new market. Ours is a traditional sector by definition – nothing is as sacred as saving lives. Introducing new solutions even within our own borders is a challenge, doing so in countries which do not share our language, culture, social structure, even more so. Swecare realised early that our secret weapon is, and despite the advent of AI will remain for some time, our partners around the world - partners who have a stake in our success: who understand the way doctors work, hospitals purchase, politicians fund, and patient seek care.
Swedish Medtech, Swecare, and InnovatioCuris
representatives signing the MoU at Vitalis 2018 in Gothenburg

This week marked another milestone in Swecare's work within the EU-funded Central Baltic Health Access project. While we served as 'local' coaches for the companies within this Swedish Medtech-led project, the success of the program was very much dependent on our 'target market' coaches. In March we signed a Memorandum of Understanding with Uganda Healthcare Federation strengthening our commitment to work together in order to support more companies in entering the Ugandan Market. And on Tuesday this week Swecare signed an MoU with Sachin Gaur of InnovatioCuris at Vitalis 2018, pledging:
  • exchange of information
  • promotion of opportunities
  • initial contact and consultation
  • networking services
Sachin has proven to be an incredible partner, with InnovatioCuris providing the companies that traveled to India under CBHA with invaluable support. He is an expert on cyber security and innovations in healthcare management. Together with his CEO Dr VK Singh, they have turned InnovatioCuris into one of the few leading consultancies focussing solely in healthcare and life sciences in India. We hope that this project is once of many more collaborations to come.

Tallinn Science Park Technopol, Uganda Healthcare Federation,
and Swecare representatives signing the MoU with
Swedish and Ugandan Ministries of Health as witness in Kampala
CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish technology organizations to support entrepreneurship in health technologies. The program facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provides the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and identifying and contacting potential partners, and business missions. The program has a strong focus for the companies to achieve sales in the chosen market. The program is financed by Central Baltic Interreg Program.

For more information on the CB Health Access program see https://www.cbhealthaccess.eu/ and visit Swecare Blog.

tisdag 31 oktober 2017

9th Session for the Indo-Swedish Joint Working Group on Health


Often referred to as the most successful MoU in our joint arsenal, the healthcare cooperation has done much to bring India and Sweden closer. Though vastly different demographically, our countries share similar challenges due to a very decentralized governance structure and a large percentage of our populations living far from health care centers. As such, many of the common challenges we face can only be overcome through collaboration and cooperation. In the coming year, ahead of the MoU's 10th anniversary, it was decided during the actual Joint Working Group meeting to take stock on what has been accomplished and explore new areas of collaboration.

For the private sector, this means we need more clarity on the recent bevy of policy changes. Although these changes for the large part have improved the business climate, they are quite confusing not only for the Swedes but Indian themselves. The Indian delegation, which included a senior representative from the Central Drugs Standard Control Organization (CDSCO), very generously shared their business cards with the Swedish companies present for the roundtable and assured each and every one of them to personally call in case of any issues.

The delegation also got a chance to see some of the Swedish products in use at Akademiska in Uppsala and was much impressed by the extremely close collaboration between professors, researchers, medical professionals, investors, and industry. While the Indian government representatives understood that these are the ingredients making Sweden such fertile ground for innovation, they had never truly appreciated how tightly, both physically and intellectually, these actors work together. This was further emphasized during their visit to EMPE Diagnostics at the Karolinska Science Park with which they ended the trip.

Going forward, Swecare, at the behest of some of our members, will focus on:
  1. the inclusion of quality criteria in public healthcare tenders - looking in not just the lowest, but the total cost, and
  2. exemptions based on global health threats (such as AMR which features prominently in the new Indian National Health Policy) for the price caps being introduced for certain Medtech products by the National Pharmaceutical Pricing Authority.
We are also working to ensure more continuity in our activities with India. Part of this will be through regularly planned trips to India and the cultivation of relationships with potential partners on the ground. If you have any suggestions or requests, do get in touch. India is a vast, and often overwhelming, country but the rewards for successful partnership could eventually affect the national and global health threats facing both Sweden and India - not to mention improve the lives of people.



fredag 29 september 2017

Central Baltic Health Access trip to India - Sept 2017

Key takeaways


1. You have to be excited to be there. If being in India does not make you happy then it will be very hard to motivate yourself and your team to invest time and money necessary to succeed in the Indian market. Two of the participants woke up at 2am to visit the Taj Mahal from Delhi (+3hrs one-way by car) before their 11am meetings with agencies and distributors. This passion speaks for itself, and the Indian counterparts are much more likely to go an extra mile (in this case quite literally) if you show that you are doing so yourself.

2. A physical presence is extremely important. Most people will actually want to meet you first and then take it from there. If, in the Swedish manner, you try to book meeting weeks in advance with a set agenda, the response is unlikely to be overwhelming. One of our Swedish delegates was so concerned with what she saw as a lack of planning that she "almost didn't come, [...] but there were so many good meetings that were unprepared!" She booked her ticket days before this CBHA trip and was not disappointed.

3. When your extremely talented and dedicated local coach tells you to take an Indian SIM card, listen to him. I regretted not having taken an old phone with me as many of my texts did not go through and data connectivity was patchy at best. There was no WiFi at the conference venue which made it difficult to follow-up and set-up meetings with the leads one had just met, an Indian number would have made life much easier.

4. Use Whatsapp - one of the representatives of a government regulatory body said that he is unlikely to ever answer an email as he is constantly running between meetings and stuck in traffic (many official domains are inaccessible on the mobile). Get potential partners' mobile numbers and use them.


About the trip


The third installment of the Central Baltic Health Access project consisted of three days in Delhi and two days in Bengaluru over the third week in September. The sheer variety of meetings we managed to fit into these few days is nothing short of impressive. For this we have Sachin Gaur and his team at InnovatioCuris to thank. I believe I speak for all participants - six from Sweden, five from Estonia, and four from Finland - when I say that it was a productive trip. Company mission reviews have started to come in and we will book in coaching meetings over the next few weeks in order to ensure follow-up, but the general feeling, even after two days in Delhi, was that many promising connections have been made - with distributors, clinics, hospitals, start-ups, research institutes, regulatory agencies.
We were also privileged to have hands-on support from both the Estonian and Swedish Embassies in Delhi. The Ambassadors spent a considerable amount of time with the companies, in order to understand the needs, challenges, and expectations of each representative. This type of local support is key for success in foreign markets. In fact Swecare is already in talks with the Embassy, Business Sweden, InnovatioCuris, Confederation of Indian Industry (CII), and Federation of Indian Chambers of Commerce & Industry (FICCI) to explore the option of making this type of business-focused trips a regular event. If you are interested in this form of deep engagement, do let us know!


Participants:


Representative name
Organization
Dr. Jaanus Pikani
Documental, Estonia
Ms. Piia Vettik-Leemet
Tartu Biotechnology Park, Estonia
Mr. Jan Erik Hedborg
ApiRays, Sweden
Mr. Priit Aigro
Smart Do, Estonia
Ms. Maarika Merirand
Tehnopol, Estonia
Dr. Pieter Spee
Fibrotx, Estonia
Ms. Malin Hollmark
Swedish Medtech, Sweden
Ms. Shampa Bari
Swecare, Sweden
Mr. Hakan Jideus
Predicare, Sweden
Mr. Pavan Asalapuram
Empe diagnostics, Sweden
Ms. Caroline Danielson
RenaPharma, Sweden
Mr. Joonas Ihalainen
iCare, Finland
Mr. Tero Karhi
Turku Science Park, Finland
Dr. Katja Heikkinen
Turku AMK, Finland
Ms. Marjatta Häsänen
Turku AMK, Finland


Food for thought


Before signing off, I leave you with some few points I have pondering over since the trip.

- If the diagnostic test costs more than the 'cure,' often antibiotics, wouldn't you too just take the latter?
- How to tackle the aging challenge, which the Indian healthcare system is only now coming to see as a threat?
- Can our products be price-competitive when there is such heavy tax imposed on imports into India? Is manufacturing there a viable option?
- When it comes to product tests, must the companies fund the research themselves, or are there easily available funds in Sweden? The Indian research agencies have such funds for the work being done on their end but cannot finance the Swedish engagement, making the PPP project less tenable.